Showing results (291-300 of 9,399) with videos related to
Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|August 22, 2002
Low-dose ritonavir moderately enhances nelfinavir exposureMichael Kurowski, Benoite Kaeser, Anthony Sawyer, et al.Clinical Pharmacology and Therapeutics|August 22, 2002
Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavirMarc Pfister, Line Labbé, Jian-Feng Lu, et al.Clinical Pharmacology and Therapeutics|August 22, 2002
Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 inductionKlaus Abraham, Alexandra Geusau, Yalcin Tosun, et al.Clinical Pharmacology and Therapeutics|August 22, 2002
Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury modelSharon M Gordon, Jaime S Brahim, Janet Rowan, et al.Clinical Pharmacology and Therapeutics|August 22, 2002
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoproteinYasuo Kurata, Ichiro Ieiri, Miyuki Kimura, et al.Clinical Pharmacology and Therapeutics|September 18, 2002
Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivoGeorge K Dresser, Vincent Wacher, Susan Wong, et al.Clinical Pharmacology and Therapeutics|September 18, 2002
Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humansBill J Gurley, Stephanie F Gardner, Martha A Hubbard, et al.Clinical Pharmacology and Therapeutics|September 18, 2002
Cytochrome P450 2E1 and 3A activities do not differ between Mexicans and European AmericansRussell A Poland, Keh-Ming Lin, Cenci Nuccio, et al.Clinical Pharmacology and Therapeutics|September 18, 2002
Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover studyRita Rachmani, Zohar Levi, Bat-Sheva Zadok, et al.Clinical Pharmacology and Therapeutics|September 18, 2002
The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteersGer-Jan Sanderink, Aimé Le Liboux, Navin Jariwala, et al.Pageof 940